Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000093751-26-000018·AGIOS PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
Agios Pharmaceuticals Inc
COMMON STOCK · CUSIP: 00847X104
Event date: 2025-12-31
- Filing-level shares
- 3,108,145.00
- Percent of class
- 5.3%
- STATE STREET CORPORATION
Shares: 3,108,145.00 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000093751-26-000018
- Form type
- SCHEDULE 13G
- Filer
- AGIOS PHARMACEUTICALS, INC.
- CIK
- CIK 1439222
- Filed
- Feb 09, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership